Evidence map›Paper›PMID 27191823›Full record

ArticleInvestigative ophthalmology & visual science2016

Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats.

Danielle M Desjardins, Phil W Yates, Mohammad Dahrouj, Yueying Liu, Craig E Crosson, Zsolt Ablonczy

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Danielle M Desjardins
Phil W Yates
Mohammad Dahrouj
Yueying Liu
Craig E Crosson
Zsolt Ablonczy
Medical University of South Carolina · US

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
TRAINING PROGRAM FOR MEDICAL SCIENTISTST32GM008716 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DEMORE, NANCY · 1999 to 2024
$9.3M
The Mechanism of the Outer Blood-Retina Barrier BreakdownR01EY019065 · NEI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ABLONCZY, ZSOLT · 2010 to 2014
$1.7M
Protein Acetylation in Glaucomatous Optic NeuropathyR01EY021368 · NEI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CROSSON, CRAIG E. · 2011 to 2014
$1.4M
South Carolina Clinical & Translational Research Institute (SCTR)TL1RR029881 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2009 to 2011
$1.1M
The Role of Acetylation in Diabetic Eye DiseaseF30EY025465 · NEI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DESJARDINS, DANIELLE M · 2015 to 2016
$97k
NCATS NIH HHS UL1 TR000062NCRR NIH HHS TL1 RR029881NEI NIH HHS F30 EY025465NEI NIH HHS R01 EY019065NEI NIH HHS R01 EY021368NIGMS NIH HHS T32 GM008716
6 · The paper itself

Abstract

purposeDiabetic macular edema (DME), an accumulation of fluid in the subretinal space, is a significant cause of vision loss. The impact of diabetes on the breakdown of the inner blood-retina barrier (BRB) is an established event that leads to DME. However, the role of the outer BRB in ocular diabetes has received limited attention. We present evidence that the breakdown of normal RPE function in hyperglycemia facilitates conditions conducive to DME pathogenesis.

methodsBrown Norway rats (130-150 g) were injected intraperitoneally with streptozotocin (STZ; 60 mg/kg) to induce hyperglycemia. After 4 weeks, Evans blue (EB) dye was injected intravenously to determine whether there was leakage of albumin into the retina. Subretinal saline blebs (0.5-1 μL) were placed 4 and 9 weeks after STZ injection, and time-lapse optical coherence tomography tracked the resorption rate. In a subset of rats, intravitreal bevacizumab, a humanized monoclonal antibody targeted to VEGF, was given at 5 weeks and resorption was measured at 9 weeks.

resultsThe ability of the RPE to transport fluid was reduced significantly after 4 and 9 weeks of hyperglycemia with a reduction of over 67% at 9 weeks. No EB dye leakage from inner retinal vessels was measured in hyperglycemic animals compared to control. The intravitreal administration of bevacizumab at week 5 significantly increased the rate of fluid transport in rats subjected to hyperglycemia for 9 weeks.

conclusionsThese results demonstrate that chronic hyperglycemia altered RPE fluid transport, in part dependent on the actions of VEGF. These results support the idea that RPE dysfunction is an early event associated with hyperglycemia that contributes to fluid accumulation in DME.

Indexed as

Diabetes Mellitus, ExperimentalAngiogenesis InhibitorsAnimalsBevacizumabBlood-Retinal BarrierCells, CulturedChronic DiseaseDiabetic RetinopathyFluorescein AngiographyFundus OculiHyperglycemiaImmunoblottingImmunohistochemistryIntravitreal InjectionsMacular EdemaRatsAngiogenesis InhibitorsBevacizumabVascular Endothelial Growth Factor A

Identifiers

PMID27191823
PMCPMC4874474
OpenAlexW2399847518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.